InvestorsHub Logo
Followers 2134
Posts 93215
Boards Moderated 0
Alias Born 12/17/2011

Re: georgie18 post# 413

Saturday, 09/08/2018 7:33:19 AM

Saturday, September 08, 2018 7:33:19 AM

Post# of 440
HOLL...16...News...Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy Resistance...

Authorized Shares
100,000,000
01/16/2018
Outstanding Shares
16,131,477
01/16/2018

https://backend.otcmarkets.com/otcapi/company/financial-report/202231/content

Details of NewStem Transaction
HMC has completed a $2 million investment in NewStem Ltd., securing an initial 20% ownership in
the company, including its technology, intellectual property and future commercial potential, at a
$10.0 million post-money valuation. HMC has also secured the right to increase its NewStem
ownership up to 33%, based on the completion of up to $2 million in follow-on contributions.
Pending the achievement of certain development milestones, HMC will contribute an additional $1
million in NewStem on each of the 12-month and 18-month anniversaries of its initial contribution.
Currently, the balance of NewStem ownership is evenly divided between Professor Nissim
Benvenisty and Yissum.

Mitchell Rubenstein – Director - Mr. Rubenstein co-founded and served as Chairman of HMC
from its inception to June 2018, during which period the company returned approximately $37
million to shareholders in the form of dividends and share repurchases, including a tender offer.
He founded Syfy Channel and numerous other media businesses.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NSTM News